About Hemmo Pharmaceuticals
Hemmo Pharmaceuticals is a Healthcare company based in Mumbai (India) founded in 1979, and was acquired by Piramal Pharma Solutions in March 2021. Synthetic peptides are manufactured for research, clinical, and commercial applications. Its Indian entity Hemmo Pharmaceuticals Private Limited reported revenue of ₹133 Cr. Its focus areas include Biopharma Outsourcing, CRO, Drug Discovery and Medicinal Chemistry. Its competitors include Sai Life Sciences, NFIL and Sapala Organics; 2 of its 3 listed competitors have raised funding.
Company details
Hemmo Pharmaceuticals was founded in 1979 and is based in Mumbai, India. Operations focus on the pharmaceutical sector, where synthetic peptides are produced for research, clinical development, and commercial use in human and veterinary industries. Products are exported globally, with bulk Oxytocin supplied to international markets. The portfolio encompasses generic active pharmaceutical ingredients, custom research peptides, clinical peptides, and peptide fragments.
- Headquarters Mumbai, India
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website hemmopharma.com
- Social LinkedIn
- Acquired by Piramal Pharma Solutions (Mar 2021)
- Legal Name Hemmo Pharmaceuticals Private Limited
- Date of Incorporation 07 Nov, 1979
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹133 Cr
FY 2021 · +45% YoY
- Net Profit₹42.70 Cr
FY 2021 · 32% margin
- EBITDA₹61.64 Cr
FY 2021 · 46% margin
- Investors
- Acquired byPiramal Pharma Solutions
(Mar 2021)
Associated legal entities of Hemmo Pharmaceuticals
Hemmo Pharmaceuticals is associated with 2 registered companies on The Company Check; the primary company is Hemmo Pharmaceuticals Private Limited. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2021) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Hemmo Pharmaceuticals Private Limited CIN U17100MH1979PTC021857 | Amalgamated | 07 Nov 1979 | Mumbai, Maharashtra | ₹133 Cr | 325 | 3 | View details |
| Hemmo Pharma Llp CIN AAF-9673 | Active | 17 Mar 2016 | Mumbai, Maharashtra | $74.3M | 3 | View details |
Investors in Hemmo Pharmaceuticals
Hemmo Pharmaceuticals has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Piramal Pharma Solutions.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Serves as a contract manufacturer of pharmaceutical products for industry partners. | 1988 | piramalpharmasolutions.com | Mumbai, India |
Investor details for Hemmo Pharmaceuticals
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Hemmo Pharmaceuticals Private Limited (Hemmo Pharmaceuticals)
Hemmo Pharmaceuticals Private Limited is the primary company behind Hemmo Pharmaceuticals. The boards of the 2 registered companies of Hemmo Pharmaceuticals currently have 5 directors; the longest-serving is Madhu Vikram Utamsingh, appointed in 2016. 13 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Madhu Vikram Utamsingh DIN 00756570 | Designated Partner | 17 Mar 2016 | 10 yrs 7 mo | Hemmo Pharma Llp, Hemmo Pharmaceuticals Private Limited |
| Vikram Utamsingh DIN 05119978 | Designated Partner | 17 Mar 2016 | 10 yrs 7 mo | Hemmo Pharma Llp |
| Rekha Jairam Hemrajani DIN 01985764 | Designated Partner | 03 Jul 2017 | 9 yrs 4 mo | Hemmo Pharma Llp |
| Surinder Bhawanidas Gulati DIN 07154673 | Director | 22 Jun 2021 | 5 yrs 4 mo | Hemmo Pharmaceuticals Private Limited |
| Amit Anant Bapat DIN 09219276 | Director | 26 Nov 2021 | 4 yrs 11 mo | Hemmo Pharmaceuticals Private Limited |
Financials of Hemmo Pharmaceuticals
Figures of Hemmo Pharmaceuticals Private Limited, the primary company behind Hemmo Pharmaceuticals, for FY 2021. Revenue was ₹133 Cr (+45% year on year). Net profit was ₹42.70 Cr (32% margin). EBITDA was ₹61.64 Cr (46% margin). Revenue has grown at a compounded annual rate of +33% over three years and +24% over five years.
- ₹133 CrRevenue · FY 2021 · +45% YoY
- ₹42.70 CrNet profit · 32% margin
- ₹61.64 CrEBITDA · 46% margin
- ₹29.1 LakhPaid-up capital
- 325Employees (provident fund records)
- +33%Revenue CAGR, 3 years
- +24%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Hemmo Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Hemmo Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Hemmo Pharmaceuticals
2 dated milestones of Hemmo Pharmaceuticals across 42 years, from founding to its latest funding, stage changes and deals.
- Founded Hemmo Pharmaceuticals is founded.
- Exit Acquired by Piramal Pharma Solutions.
Competitors of Hemmo Pharmaceuticals
Hemmo Pharmaceuticals has 3 listed competitors in our database, 2 of them funded. They include Sai Life Sciences, NFIL and Sapala Organics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| sailife.com | 1999 | Hyderabad, India | $112.18M | 2,948 | Complex small molecules are discovered, developed, and manufactured for pharmaceuticals. | |
| nfil.in | 1967 | Mumbai, India | 1,476 | Fluorinated compounds are synthesized and manufactured customly for various industries. | ||
| sapalaorganics.com | 2005 | Hyderabad, India | $734,962 | 219 | Research organization specializing in custom synthesis of various organic compounds |
Detailed competitors of Hemmo Pharmaceuticals
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Hemmo Pharmaceuticals (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 2,062 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 548 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 557 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Hemmo Pharmaceuticals
Complete news archive for Hemmo Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hemmo Pharmaceuticals
Hemmo Pharmaceuticals was founded in 1979.
Hemmo Pharmaceuticals is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
The primary company behind Hemmo Pharmaceuticals, Hemmo Pharmaceuticals Private Limited, reported revenue of ₹133 Cr for FY 2021, up 45% year on year.
Hemmo Pharmaceuticals was founded in 1979 and is based in Mumbai, India. Operations focus on the pharmaceutical sector, where synthetic peptides are produced for research, clinical development, and commercial use in human and veterinary industries. Products are exported globally, with bulk Oxytocin supplied to international markets. The portfolio encompasses generic active pharmaceutical ingredients, custom research peptides, clinical peptides, and peptide fragments.
Hemmo Pharmaceuticals's top competitors include Sai Life Sciences, NFIL and Sapala Organics.
Hemmo Pharmaceuticals has 1 investor. Key investors include Piramal Pharma Solutions.
Hemmo Pharmaceuticals is associated with 2 legal entities: Hemmo Pharmaceuticals Private Limited, Hemmo Pharma Llp.
Yes. Hemmo Pharmaceuticals was acquired by Piramal Pharma Solutions in March 2021.
The legal entities of Hemmo Pharmaceuticals currently have 5 directors, including Rekha Jairam Hemrajani, Madhu Vikram Utamsingh, Vikram Utamsingh and others.